- Sold 2 unencumbered properties for $16.4 million in Q2, with an additional 3 properties sold in July for $8.8 million.
- Active disposition pipeline includes 53 properties, with 49 under agreements or LOIs for $280 million, mainly in Q3 and Q4.
- Dispositions aim to retire 2026 notes, reduce leverage, and reposition portfolio towards higher-growth SHOP assets.
- Expect most asset sales to close in Q3 and Q4, supporting balance sheet improvement and cash flow enhancement.
Explore Similar Insights
- Transformational renovations at key properties in South Florida, Hawaii, and New York impacted Q2 RevPAR, with ramp-up expected in Q4.
- Repositioning efforts include high-occupancy assets and high-value conversions, such as Nashville, Houston Medical Center, and Pittsburgh.
- Renovations and closures, like the Austin Convention Center, caused temporary declines but are expected to support future growth.
- Management highlighted the importance of asset upgrades in driving operational upside and long-term value.
- Proactive sale of $60 million in nonowner-occupied CRE hospitality loans during the quarter.
- Resulted in a net $2 million gain and allowed the reversal of related reserves, leading to no provision for the quarter.
- Part of ongoing balance sheet optimization and risk reduction efforts.
- Capital expenditures and leasing commissions year-to-date totaled $5.2 million, with full-year guidance between $12 million and $14 million.
- Global Medical REIT reported a second quarter 2025 dividend reduction from $0.21 to $0.15 per share, reflecting a rightsizing aligned with dividend coverage dropping from 110% to 79% on a FAD basis.
- Occupancy as of June 30, 2025, stood at 94.5%, down from the first quarter due to lease expirations and tenant bankruptcies, with expectations to end the year above 95%.
- The company completed a $150 million acquisition of a five-property outpatient medical real estate portfolio at an 8.5% blended going-in cash yield.